Free Trial

Ambu A/S Q2 2023 Earnings Report

Ambu A/S logo
$17.06 0.00 (0.00%)
As of 04/3/2025

Ambu A/S EPS Results

Actual EPS
$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ambu A/S Revenue Results

Actual Revenue
$174.62 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Ambu A/S Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Remove Ads

Ambu A/S Earnings Headlines

3 Growth Stocks Insiders Own With Up To 39% Earnings Growth
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Ambu A/S goes ex dividend tomorrow
Ambu A/S (AMBBY)
Ambu A/S Reports Strong Growth and Strategic Advancements
See More Ambu A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ambu A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ambu A/S and other key companies, straight to your email.

About Ambu A/S

Ambu A/S (OTCMKTS:AMBBY) develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

View Ambu A/S Profile

More Earnings Resources from MarketBeat